Portfolio
3
companies
Tendertec
Tendertec develops an artificial intelligence platform to support elderly care and independent living.
MicrofluidX
MicrofluidX provides next-generation bioreactors for cell research and manufacturing.
Kinomica
Kinomica develops proteomic data science platforms to advance precision cancer treatments.
Will Chawner
Investor
The Development Bank of Wales led the round to support the commercialisation of the company's caregiving technology.
"The elderly population is rapidly growing, and the care sector is struggling to keep pace. We need over a 50% increase in paid carers by 2030 to ensure adequate care. The current situation calls for innovative AI solutions, like Hestia, to address the urgent need for caregivers and fulfil the care sector’s economic and job creation potential,"
The Stevenage enterprise raised the capital from Longwall Ventures and a syndicate of backers to fund trials and product development.
"Advanced therapy manufacturing is hindered by out of date, inadequate manufacturing technologies,"
The seed round was co-led by BGF and Longwall Venture Partners with participation from seed backers including BioCity, Alderley Park Ventures, and Puffin Point.
"This marks a huge step forward for Kinomica and for KScan™, as we look to the future of cancer treatment. Our pioneering technology offers much-needed support for the development of new precision medicines and represents a new approach to drug trials and treatments that will have a huge impact on patients’ lives."
